Evaluating a Panel of Autoantibodies Against Tumor-Associated Antigens in Human Osteosarcoma

被引:1
|
作者
Luo, Manli
Wu, Songmei
Ma, Yan
Liang, Hong
Luo, Yage
Gu, Wentao
Fan, Lijuan
Hao, Yang
Li, Haiting
Xing, Linbo
机构
[1] Luoyang Orthopedic Hospital of Henan Province (Orthopedic Hospital of Henan Province), Luoyang
[2] Henan Provincial Rehabilitation Hospital, Luoyang
关键词
osteosarcoma; tumor-associated antigen; autoantibody; detection; early diagnosis; panel; SEROLOGICAL PROTEOME ANALYSIS; HEPATOCELLULAR-CARCINOMA; CANCER; EXPRESSION; BIOMARKERS; PROGNOSIS; ENOLASE-1; DIAGNOSIS;
D O I
10.3389/fgene.2022.872253
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The aim of this study was to identify a panel of candidate autoantibodies against tumor-associated antigens in the detection of osteosarcoma (OS) so as to provide a theoretical basis for constructing a non-invasive serological diagnosis method in early immunodiagnosis of OS.Methods: The serological proteome analysis (SERPA) approach was used to select candidate anti-TAA autoantibodies. Then, indirect enzyme-linked immunosorbent assay (ELISA) was used to verify the expression levels of eight candidate autoantibodies in the serum of 51 OS cases, 28 osteochondroma (OC), and 51 normal human sera (NHS). The rank-sum test was used to compare the content of eight autoantibodies in the sera of three groups. The diagnostic value of each indicator for OS was analyzed by an ROC curve. Differential autoantibodies between OS and NHS were screened. Then, a binary logistic regression model was used to establish a prediction logistical regression model.Results: Through ELISA, the expression levels of seven autoantibodies (ENO1, GAPDH, HSP27, HSP60, PDLIM1, STMN1, and TPI1) in OS patients were identified higher than those in healthy patients (p < 0.05). By establishing a binary logistic regression predictive model, the optimal panel including three anti-TAAs (ENO1, GAPDH, and TPI1) autoantibodies was screened out. The sensitivity, specificity, Youden index, accuracy, and AUC of diagnosis of OS were 70.59%, 86.27%, 0.5686, 78.43%, and 0.798, respectively.Conclusion: The results proved that through establishing a predictive model, an optimal panel of autoantibodies could help detect OS from OC or NHS at an early stage, which could be used as a promising and powerful tool in clinical practice.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer
    Jiang, Di
    Wang, Yulin
    Liu, Man
    Si, Qiufang
    Wang, Tingting
    Pei, Lu
    Wang, Peng
    Ye, Hua
    Shi, Jianxiang
    Wang, Xiao
    Song, Chunhua
    Wang, Kaijuan
    Dai, Liping
    Zhang, Jianying
    [J]. IMMUNOBIOLOGY, 2020, 225 (01)
  • [2] Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer
    Hoshino, Isamu
    Nagata, Matsuo
    Takiguchi, Nobuhiro
    Nabeya, Yoshihiro
    Ikeda, Atsushi
    Yokoi, Sana
    Kuwajima, Akiko
    Tagawa, Masatoshi
    Matsushita, Kazuyuki
    Satoshi, Yajima
    Hideaki, Shimada
    [J]. CANCER SCIENCE, 2017, 108 (03) : 308 - 315
  • [3] Detection of autoantibodies against tumor-associated antigens (TAAs) improving immunodiagnosis in human osteosarcoma by serological proteome analysis
    Li, Jitian
    Huang, Manyu
    Luo, Manli
    Dai, Liping
    Xie, Wen
    Qin, Xiaofei
    Han, Zongchang
    Li, Wuyin
    Zhang, Jianying
    [J]. CANCER RESEARCH, 2017, 77
  • [4] A panel of autoantibodies against multiple tumor-associated antigens in the early immunodiagnosis of lung cancer
    Jiang, Di
    Wang, Tingting
    Pei, Lu
    Wang, Peng
    Ye, Hua
    Song, Chunhua
    Wang, Kaijuan
    Zhang, Jianying
    Dai, Liping
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [5] Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer
    Sun, Hao
    Shi, Jian-Xiang
    Zhang, Hong-Fei
    Xing, Meng-Tao
    Li, Pei
    Dai, Li-Ping
    Luo, Cheng-Lin
    Wang, Xiao
    Wang, Peng
    Ye, Hua
    Li, Liu-Xia
    Zhang, Jian-Ying
    [J]. TUMOR BIOLOGY, 2017, 39 (06)
  • [6] A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer
    Hong-Fei Zhang
    Jie-Jie Qin
    Peng-Fei Ren
    Jian-Xiang Shi
    Jun-Fen Xia
    Hua Ye
    Peng Wang
    Chun-Hua Song
    Kai-Juan Wang
    Jian-Ying Zhang
    [J]. Cancer Immunology, Immunotherapy, 2016, 65 : 1233 - 1242
  • [7] A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer
    Zhang, Hong-Fei
    Qin, Jie-Jie
    Ren, Peng-Fei
    Shi, Jian-Xiang
    Xia, Jun-Fen
    Ye, Hua
    Wang, Peng
    Song, Chun-Hua
    Wang, Kai-Juan
    Zhang, Jian-Ying
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (10) : 1233 - 1242
  • [8] Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma
    Yu Hong
    Jian Huang
    [J]. World Journal of Hepatology, 2015, (11) : 1581 - 1585
  • [9] Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma
    Hong, Yu
    Huang, Jian
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (11) : 1581 - 1585
  • [10] Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies
    Chen, Xiaohong
    Fu, Songbin
    Chen, Feng
    Chen, Huanyong
    Chen, Zhi
    [J]. ONCOLOGY REPORTS, 2008, 20 (04) : 979 - 985